FZ-AD005

· Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FZ-AD005, covering 2026-03-04 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) [Phase 1]